Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
All content for Oncology Unscripted is the property of Katie Coleman, Julie Johnson, Matt Spraker and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
Send us a text Patient advocates Julie Johnson and Katie Coleman team up with radiation oncologist Dr. Matt Spraker to "meet in the middle" for a candid podcast about cancer care for patients and people working in field. In this episode we discuss the second opinion, seeking an alternate recommendation from a different doctor outside the main team. We start by reviewing Katie's Twitter polls that asked patients' and doctors' their feelings on the topic. We then some cases where secon...
Oncology Unscripted
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
